Vaso Corporation (VASO)
OTCMKTS · Delayed Price · Currency is USD
0.1211
-0.0039 (-3.12%)
Sep 18, 2025, 3:15 PM EDT
Vaso Corporation Market Cap
Vaso Corporation has a market cap or net worth of $21.27 million as of September 18, 2025. Its market cap has decreased by -51.50% in one year.
Market Cap
21.27M
Enterprise Value
-8.35M
Revenue
87.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since June 15, 1992, Vaso Corporation's market cap has decreased from 36.04M to 21.27M, a decrease of -40.99%. That is a compound annual growth rate of -1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 21.28M | 1.12% |
| Dec 31, 2024 | 21.05M | -60.64% |
| Dec 29, 2023 | 53.47M | 85.05% |
| Dec 30, 2022 | 28.90M | 202.47% |
| Dec 31, 2021 | 9.55M | -38.56% |
| Dec 31, 2020 | 15.55M | 202.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |